This Fool highlights a pair of excellent blue-chip stocks that he'd buy today and tuck away in a SIPP portfolio for the long run. The post 2 superb FTSE 100 stocks I’d buy for a SIPP and hold for a decade appeared first on The Motley Fool UK.
AbelZeta Pharma, Inc. ("AbelZeta" or the "Company"), a global clinical-stage biopharmaceutical company focused on the discovery and development of innovative and proprietary cell-based therapeutic products, today announced preliminary safety and efficacy results from its first time in human investigator-initiated trial (IIT) of C-CAR031 in connection with the Company's oral presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting. The presentation shared data indicati
In the latest trading session, Astrazeneca (AZN) closed at $78.99, marking a +1.24% move from the previous day.